Trial
NCT05514912
Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Emory University
Collaborators
National Cancer Institute (NCI)
Condition
Resectable Intrahepatic Cholangiocarcinoma
Intervention
Cisplatin
Why stopped
PI has decided to terminate this study due to study supporter pulling support on this study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-12-26